Tatva Chintan Pharma Chem · Material risks, their source context, and severity in the latest available quarter.
ConCallIQ research layer
Use the controls below to narrow the view, then follow the evidence into the next layer of context.
Risk intelligence
Amines prices increased 30-40% due to geopolitical tensions following the Iran situation in March. While most customers accepted price pass-through, some only allow raw material price impact pass-through, creating margin pressure in certain contracts.
Analyst raised concerns about ACT (likely Atorvastatin) volumes impacting customer demand. Management clarified Tatva has insignificant volume share in customers' total demand, providing resilience, though this represents a segment-level risk for pharmaceutical intermediates.
SDA market has only two suppliers who maintain balance - management confirmed maximum market share per customer capped at ~70% as customers deliberately keep both suppliers engaged. This structural dynamic limits upside from individual customer relationships.
Project was delayed 4-6 weeks due to detailed engineering feedback requiring process optimization trials. While this reduced reactor count and improved long-term efficiency, similar feedback loops during construction phase could impact the 18-20 month timeline.
